Securities code: Shanghai Gentech Co.Ltd(688596) securities abbreviation: Shanghai Gentech Co.Ltd(688596) Announcement No.: 2022008 Shanghai Gentech Co.Ltd(688596)
Suggestive announcement on the change of shareholders’ equity holding more than 5%
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law.
Important content tips:
● this equity change is the shareholder of the company, Yangzhou Fuyi Juneng equity investment partnership (limited partnership) (formerly renamed “Ningbo quantum Juneng Investment Center (limited partnership)”, Hereinafter referred to as “Yangzhou Fuyi” or “information disclosure obligor”) for fulfilling the announcement on the share reduction plan of shareholders holding more than 5% of Shanghai Gentech Co.Ltd(688596) shares (Announcement No.: 2021061) and carrying out refinancing business disclosed by Shanghai Gentech Co.Ltd(688596) (hereinafter referred to as “the company”) on the website of Shanghai Stock Exchange on November 20, 2021, As a result, the company’s shares held by Yangzhou Fuyi changed in equity.
● this equity change is to fulfill the previously disclosed share reduction plan and carry out refinancing business, and does not touch the tender offer.
● this equity change will not lead to changes in the controlling shareholders and actual controllers of the company.
● after this equity change, the total number of shares held by the information disclosure obligor is 12824744 shares, accounting for 4.9999% of the total share capital of the company.
The company received the short form equity change report issued by Yangzhou Fuyi on March 11, 2022. As of March 11, 2022, the above shareholders held less than 5% of the company’s shares. Now the relevant equity changes are announced as follows:
1、 Changes in equity this time
(I) basic information of the information disclosure obligor
1.1 as of the date of issuance of this report, the basic information of the information disclosure obligor is as follows:
Name: Yangzhou Fuyi Juneng equity investment partnership (limited partnership)
Registered address: room 180, building 7, huaduhui business center, No. 195, thin West Lake Road, Shugang thin West Lake scenic spot, Yangzhou City
Executive partner Zhu Deyu
Subscribed capital (yuan): 55.069 million yuan
Unified social credit code 91330206340563686d
Type of enterprise: limited partnership
Date of establishment: September 18, 2015
Operation period: September 18, 2015 to September 17, 2035
General items: equity investment; Information consulting services (excluding the information consulting services of licensed business scope) (except for the items that must be approved according to law, carry out business activities independently according to law with the business license)
Partners and capital contributions are as follows:
No. name of partner total subscribed capital contribution (10000 yuan) proportion of subscribed capital contribution
1 Zhu Deyu 1 001816%
2 Zhou Tong 15 Kennede Electronics Mfg.Co.Ltd(002723) 856%
3 yangmengmei 12 Avic Jonhon Optronic Technology Co.Ltd(002179) 084%
4 Qi Fang 800 1452723%
5 Tan Jianbo 500 907952%
6 Xu Ying 407 739073%
7 Chen Siyu 185 335942%
8 Chen Yueli 185 335942%
9 Li Fang 148 268754%
10 Yu Chunyang 148 268754%
11 Liu Shudong 118.4 215003%
12 Shi Hong 92.5 167971%
13 Liu Su 92.5 167971%
14 Jiang rujiao 74 134377%
15 Shi Yun 37 067188%
16 Yu Feng 18.5 033594%
(II) basic information of this equity change
1. From December 13, 2021 to December 31, 2021, Yangzhou Fuyi reduced 295558 shares of the company through the stock trading system of Shanghai stock exchange through centralized bidding trading, accounting for 0.1152% of the total share capital of the company. For details, see the company’s announcement on Shanghai Stock Exchange (www.sse. Com. Cn.) on January 27, 2022 Announcement of Shanghai Gentech Co.Ltd(688596) shareholders reducing their shares by more than half and progress of reduction (Announcement No.: 2022002) disclosed.
From February 28, 2022 to March 11, 2022, Yangzhou Fuyi reduced 703211 shares of the company through the stock trading system of Shanghai stock exchange through centralized bidding trading, accounting for 0.2742% of the total share capital of the company. To sum up, from December 13, 2021 to March 11, 2022, Yangzhou Fuyi reduced 998769 shares of the company through the stock trading system of Shanghai stock exchange through centralized bidding trading, accounting for 0.3894% of the total share capital of the company.
2. From February 25, 2022 to March 2, 2022, Yangzhou Fuyi lent 1060000 shares of the company due to refinancing business, accounting for 0.4133% of the total share capital of the company.
After this equity change, Yangzhou Fuyi held 12824744 shares of the company, accounting for 4.9999% of the total share capital of the company.
(III) Shareholding before and after this equity change
Shares held before equity change name of shareholders holding shares after equity change shareholding nature shareholding ratio number of shares (shares) shareholding proportion number of shares (shares)
example
Total shares held 148835135.80% 128247444.9999% Yangzhou Fuyi, including: unlimited conditional flow
148835135.80% 128247444.9999% Tong shares
Note: 1. From February 25, 2022 to March 2, 2022, Yangzhou Fuyi lent part of the company’s non tradable shares to China Securities Finance Co., Ltd. through the securities trading platform, and the number of shares Lent was 1060000.
2. All the shares involved in this equity change enjoy voting rights, and there are no restrictions on the transfer of voting rights, such as delegation or restriction of voting rights.
3. This change does not violate the securities law, the measures for the administration of the acquisition of listed companies and other laws and regulations, the business rules of Shanghai Stock Exchange and other relevant provisions and relevant commitments.
4. The difference in the mantissa of the data in this announcement is caused by rounding.
5. After this equity change, the information disclosure obligor is no longer the shareholder holding more than 5% of the company’s shares.
2、 Follow up matters involved
1. This equity change is to fulfill the previously disclosed share reduction plan and carry out refinancing business, and does not touch the tender offer;
2. This equity change will not lead to changes in the controlling shareholder and actual controller of the company;
3. According to the securities law of the people’s Republic of China, the measures for the administration of the acquisition of listed companies and other relevant provisions, this change in shareholders’ equity involves the disclosure of the report on changes in shareholders’ equity disclosed by the information disclosure obligor. For details, see the website of Shanghai Stock Exchange on the same day (www.sse. Com. CN.) Shanghai Gentech Co.Ltd(688596) simplified equity change report disclosed;
4. After this equity change, the information disclosure obligor is no longer a shareholder with a total shareholding of more than 5% and is still in the implementation period of its reduction plan. The company will urge it to strictly abide by the relevant reduction regulations and disclose relevant information to the majority of investors in time. Please pay attention to the investment risk.
It is hereby announced.
Shanghai Gentech Co.Ltd(688596) board of directors March 12, 2022
